About Embark Biotech
Embark Biotech is a company based in Copenhagen (Denmark) founded in 2017 by Thue Schwartz was acquired by Novo Nordisk in August 2023.. The company has 3 employees as of December 31, 2021. Embark Biotech operates in a competitive market with competitors including Adocia, Altimmune, Carmot, BioAge Labs and Fractyl, among others.
- Headquarter Copenhagen, Denmark
- Employees 3 as on 31 Dec, 2021
- Founders Thue Schwartz
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Embark Biotech Aps
-
Annual Revenue
-
Net Profit
$488.07 K (USD)-78as on Dec 31, 2020
-
EBITDA
-
Latest Funding Round
- Investors
-
Employee Count
3
as on Dec 31, 2021
-
Acquired by
Novo Nordisk
(Aug 28, 2023)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Embark Biotech
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Embark Biotech
Embark Biotech has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Novo Nordisk. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Drugs for diabetes, obesity, hemophilia, and hormone therapy are manufactured.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Embark Biotech
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Embark Biotech
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Embark Biotech Comparisons
Competitors of Embark Biotech
Embark Biotech operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Adocia, Altimmune, Carmot, BioAge Labs and Fractyl, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Therapeutics for diabetes and obesity treatment are developed.
|
|
| domain | founded_year | HQ Location |
Vaccines for infectious diseases and solid tumors are developed.
|
|
| domain | founded_year | HQ Location |
Disease-modifying therapies for metabolic diseases are developed.
|
|
| domain | founded_year | HQ Location |
Bioinformatics platform is provided for biomarkers and drug discovery.
|
|
| domain | founded_year | HQ Location |
Endoscopic procedures for type-2 diabetes treatment are developed.
|
|
| domain | founded_year | HQ Location |
Peptide-based therapies for obesity and cardiometabolic disorders are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Embark Biotech
Frequently Asked Questions about Embark Biotech
When was Embark Biotech founded?
Embark Biotech was founded in 2017.
Where is Embark Biotech located?
Embark Biotech is headquartered in Copenhagen, Denmark.
How many employees does Embark Biotech have?
As of Dec 31, 2021, the latest employee count at Embark Biotech is 3.
What does Embark Biotech do?
Embark Biotech was founded in 2017 in Copenhagen, Denmark, within the biotechnology sector. Focus is placed on developing therapeutics to address metabolic diseases and obesity. Operations center on innovative products, including EMB1, a peptide targeted at hyperphagia, and EMB2, a small molecule designed for obesity treatment. Research and development activities are conducted to advance these solutions for clinical applications.
Who are the top competitors of Embark Biotech?
Embark Biotech's top competitors include Adocia, BioAge Labs and Fractyl.
Who are Embark Biotech's investors?
Embark Biotech has 1 investor. Key investors include Novo Nordisk.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.